Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Melamed

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Medicine|February 13, 2026
Reducing Polypharmacy-Related Adverse Outcomes in Older Adults with Chronic Kidney Disease: A Retrospective Cohort Study of a Digitally Mediated Pharmacist InterventionKeren Dopelt, Ori Mayer, Adir Dagan, et al.
Cancers|May 13, 2026
Histologic Transformation in Follicular Lymphoma: Real-World Outcomes with Rituximab vs. Obinutuzumab-Based CombinationsDor Shpitzer, Chava Perry, Tamir Shragai, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|November 10, 2025
Mean platelet volume and long-term cardiovascular outcomes in patients with type 2 diabetes mellitusShani Dahan, Ygal Plakht, Arthur Shiyovich, et al.
American Journal of Hematology|September 3, 2025
Triple A Plus (AAA<sup>+</sup>) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 PatientsAyalew Tefferi, Giuseppe G Loscocco, Lior Rokach, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Medicine|February 13, 2026
Reducing Polypharmacy-Related Adverse Outcomes in Older Adults with Chronic Kidney Disease: A Retrospective Cohort Study of a Digitally Mediated Pharmacist InterventionKeren Dopelt, Ori Mayer, Adir Dagan, et al.
Cancers|May 13, 2026
Histologic Transformation in Follicular Lymphoma: Real-World Outcomes with Rituximab vs. Obinutuzumab-Based CombinationsDor Shpitzer, Chava Perry, Tamir Shragai, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|November 10, 2025
Mean platelet volume and long-term cardiovascular outcomes in patients with type 2 diabetes mellitusShani Dahan, Ygal Plakht, Arthur Shiyovich, et al.
American Journal of Hematology|September 3, 2025
Triple A Plus (AAA<sup>+</sup>) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 PatientsAyalew Tefferi, Giuseppe G Loscocco, Lior Rokach, et al.
Pageof 3